Striatal β-amyloid deposition in Parkinson disease with dementia

被引:9
|
作者
Jellinger, Kurt A. [1 ]
机构
[1] Lainz Hosp, Ludwig Boltzmann Inst Clin Neurobiol, A-1130 Vienna, Austria
关键词
D O I
10.1097/NEN.0b013e3181713cb1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:484 / 484
页数:1
相关论文
共 50 条
  • [31] Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
    Gomperts, Stephen N.
    Locascio, Joseph J.
    Rentz, Dorene
    Santarlasci, Andrea
    Marquie, Marta
    Johnson, Keith A.
    Growdon, John H.
    [J]. NEUROLOGY, 2013, 80 (01) : 85 - 91
  • [32] PARKINSON'S DISEASE DEMENTIA: AT THE CROSSROADS OF α-SYNUCLEIN, TAU AND AMYLOID-β
    Irwin, David
    Lee, V.
    Trojanowski, J.
    [J]. NEUROBIOLOGY OF AGING, 2014, 35 : S11 - S11
  • [33] Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia
    Paul Edison
    Imtiaz Ahmed
    Zhen Fan
    Rainer Hinz
    Giorgio Gelosa
    K Ray Chaudhuri
    Zuzana Walker
    Federico E Turkheimer
    David J Brooks
    [J]. Neuropsychopharmacology, 2013, 38 : 938 - 949
  • [34] Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia
    Ishizawa, Kunihiko
    Fujita, Yukio
    Nagashima, Kazuaki
    Nakamura, Takumi
    Shibata, Makoto
    Kasahara, Hiroo
    Makioka, Kouki
    Taketomi-Takahashi, Ayako
    Hirasawa, Hiromi
    Higuchi, Tetsuya
    Tsushima, Yoshito
    Ikeda, Yoshio
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 451
  • [35] A Florbetapir [F18] amyloid PET Imaging study in Parkinson's disease Dementia (PDD): The influence of amyloid deposition on cognitive status and course of disease progression
    Palermo, G.
    Aghakhanyan, G.
    Tommasini, L.
    Frosini, D.
    Volterrani, D.
    Bonuccelli, U.
    Ceravolo, R.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S710 - S711
  • [36] Imaging Amyloid in Parkinson's Disease Dementia and Dementia with Lewy Bodies with Positron Emission Tomography
    Brooks, David J.
    [J]. MOVEMENT DISORDERS, 2009, 24 (14) : S742 - S747
  • [37] CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
    Bibl, M
    Mollenhauer, B
    Esselmann, H
    Lewczuk, P
    Klafki, HW
    Sparbier, K
    Smirnov, A
    Cepek, L
    Trenkwalder, C
    Rüther, E
    Kornhuber, J
    Otto, M
    Wiltfang, J
    [J]. BRAIN, 2006, 129 : 1177 - 1187
  • [38] Pathophysiology of Parkinson's disease. Will Amyloid loading PET help predict dementia in Parkinson's disease?
    Lorenzo-Bosquet, Carles
    Miquel-Rodriguez, Francesc
    [J]. REVISTA DE NEUROLOGIA, 2010, 50 : S24 - S25
  • [39] Prevalence of amyloid-β deposition in the cerebral cortex in Parkinson's disease
    Mastaglia, FL
    Johnsen, RD
    Byrnes, ML
    Kakulas, BA
    [J]. MOVEMENT DISORDERS, 2003, 18 (01) : 81 - 86
  • [40] THE ROLE APOMORPHINE AS A POTENTIAL MODIFIER OF AMYLOID DEPOSITION IN PARKINSON'S DISEASE
    Rakhimov, F.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E57 - E58